A transcriptomic based deconvolution framework for assessing differentiation stages and drug responses of AML.
Karakaslar EO, Severens JF, Sánchez-López E, van Veelen PA, Zlei M, van Dongen JJM, Otte AM, Halkes CJM, van Balen P, Veelken H, Reinders MJT, Griffioen M, van den Akker EB.
Karakaslar EO, et al. Among authors: sanchez lopez e.
NPJ Precis Oncol. 2024 May 18;8(1):105. doi: 10.1038/s41698-024-00596-9.
NPJ Precis Oncol. 2024.
PMID: 38762545
Free PMC article.